- CERN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $97.4 million.
- CERN is down 3.9% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CERN with the Ticky from Trade-Ideas. See the FREE profile for CERN NOW at Trade-Ideas More details on CERN: Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers in the United States and internationally. CERN has a PE ratio of 48.0. Currently there are 20 analysts that rate Cerner a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Cerner has been 1.5 million shares per day over the past 30 days. Cerner has a market cap of $24.8 billion and is part of the technology sector and computer software & services industry. The stock has a beta of 0.87 and a short float of 4.6% with 9.66 days to cover. Shares are up 11.5% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Cerner as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Highlights from the ratings report include:
- Despite its growing revenue, the company underperformed as compared with the industry average of 21.9%. Since the same quarter one year prior, revenues rose by 16.4%. Growth in the company's revenue appears to have helped boost the earnings per share.
- CERN's debt-to-equity ratio is very low at 0.04 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Along with this, the company maintains a quick ratio of 3.30, which clearly demonstrates the ability to cover short-term cash needs.
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Health Care Technology industry and the overall market, CERNER CORP's return on equity exceeds that of both the industry average and the S&P 500.
- Powered by its strong earnings growth of 147.05% and other important driving factors, this stock has surged by 39.98% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, CERN should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- CERNER CORP reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, CERNER CORP increased its bottom line by earning $1.50 versus $1.13 in the prior year. This year, the market expects an improvement in earnings ($2.11 versus $1.50).
- You can view the full Cerner Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.